See All Slides - tctmd.com

Slides

Presentation TCT 2012

Multivessel Disease 2: Use of Physiologic Lesion Assessment and IVUS to Improve DES Results

Presenter: Seung-Jung Park

October 22, 2012

Presentation TCT 2012

The Art and Science of Risk Stratification in Aortic Stenosis: Updates on Risk Scores, Futility, and Other Imponderables

Presenter: Michael Mack

October 22, 2012

Presentation TCT 2012

BUT May Also Increase Stroke

Presenter: Josep Rodes-Cabau

October 22, 2012

Presentation TCT 2012

“Nuggets” on Patient Selection After > 1,000 TAVR Cases (Performed and/or Proctored): Self-Expanding TAVR

Presenter: Ganesh Manoharan

October 22, 2012

Presentation TCT 2012

Safety of the Stop-flow Intracoronary Technique: Single-center Experience

Presenter: Andreas Zeiher

October 22, 2012

Presentation TCT 2012

Debate I. Are Drug-Eluting Stents Now the Default Strategy for SFA Intervention? - Pro!

Presenter: Gary Ansel

October 22, 2012

Presentation TCT 2012

Do Patient and Stent Platform Specific Variables Matter (e.g. ACS vs. Stable CAD, First vs. Second Generation DES)?

Presenter: Elvin Kedhi

October 22, 2012

Presentation TCT 2012

Improved Patient Screening, Meticulous Access and Closure Techniques, and Lower Profile Catheter Systems Can Reduce Major Vascular Complications to <5%: The Vancouver Experience

Presenter: John Webb

October 22, 2012

Presentation TCT 2012

New Data from PARTNER Continued Access (Non-randomized): Transapical Outcomes After TAVR

Presenter: Todd Dewey

October 22, 2012

Presentation TCT 2012

Provisional Stenting Technique: Step by Step Tutorial (Including Crossover Techniques)

Presenter: Yves Louvard

October 22, 2012

Advertisement

Slides

Multivessel Disease 2: Use of Physiologic Lesion Assessment and IVUS to Improve DES Results

The Art and Science of Risk Stratification in Aortic Stenosis: Updates on Risk Scores, Futility, and Other Imponderables

BUT May Also Increase Stroke

“Nuggets” on Patient Selection After > 1,000 TAVR Cases (Performed and/or Proctored): Self-Expanding TAVR

Safety of the Stop-flow Intracoronary Technique: Single-center Experience

Debate I. Are Drug-Eluting Stents Now the Default Strategy for SFA Intervention? - Pro!

Do Patient and Stent Platform Specific Variables Matter (e.g. ACS vs. Stable CAD, First vs. Second Generation DES)?

Improved Patient Screening, Meticulous Access and Closure Techniques, and Lower Profile Catheter Systems Can Reduce Major Vascular Complications to <5%: The Vancouver Experience

New Data from PARTNER Continued Access (Non-randomized): Transapical Outcomes After TAVR

Provisional Stenting Technique: Step by Step Tutorial (Including Crossover Techniques)

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content